Paul Oldham
Analyst · D.A. Davidson. Your line is open. Please go ahead
Thank you, Yuval and good morning, everyone. Before I begin, please note that all financial measures presented today will be on a non-GAAP basis, unless otherwise stated. Excluded from non-GAAP results our amortization, stock compensation, integration and transition costs, unrealized foreign exchange gains and losses, and restructuring items. This quarter, we recorded $5.8 million in restructuring costs related to the transition of manufacturing from Shenzhen to Malaysia, and other actions associated with synergies related to the Artesyn acquisition. We also recorded $1.1 million in non-cash unrealized FX losses related to long-term lease and pension liabilities. A full reconciliation from GAAP to non-GAAP measures can be found in our press release issued earlier today. In our second quarter, we delivered outstanding financial results, exceeding expectations and guidance for revenue, gross margin, operating margin and cash flow generation. Our team's strong execution in the challenging environment enabled our non-GAAP EPS to be above our widened range and our annualized return on invested capital to increase to over 20%. Cash increased by $28 million and we generated additional synergies from the integration of Artesyn. Second quarter revenue was a record $340 million, up 7.7% from $315 million last quarter and up 152% from $135 million a year ago. On a pro forma basis, including a full quarter of Artesyn revenue in prior periods, Q2 revenue grew 24% year-over-year with strong growth in semiconductor and data center computing markets, partially offset by declines in industrial and medical, and telecom and networking. Excluding Artesyn, organic revenue grew 11.5% sequentially and 34% year-over-year to $180 million. Turning to revenue by market, sales in semiconductor in Q2 were $145 million, up nearly 9% from the strong first quarter and up 61% year-over-year. On an organic basis, semi revenue grew 60% year-over-year with strong demand from foundry logic and higher investment in NAND memory. Semi product sales were up over 9% sequentially and 88% year-over-year. Semi service revenue also grew about 9% from last quarter, but declined 8% from last year due to COVID-19 related capacity constraints in some of our service centers. Overall, our semiconductor revenues have grown faster than WFE and the vast majority of our peers, both year-to-date and year-over-year in Q2. Revenue from our industrial and medical markets was $71 million, up 14% sequentially as a result of growth related to critical care medical devices, increased thin film market demand and our improved ability to deliver products. On a pro forma basis, revenue declined 23% year-over-year driven by general macro weakness in several of our industrial sectors, exacerbated by the COVID-19 crisis. Data center computing revenue was $83 million, down 3% from the exceptionally strong first quarter, but up 89% year-over-year on a pro forma basis. Hyperscale continued to grow, offset by lower enterprise revenues mainly due to capacity constraints in our Philippine facility. Telecom and networking revenue was $40 million, up nearly 20% sequentially on solid shipments of our design wins. On a pro forma basis, revenues declined almost 14% year-over-year as the global telecom infrastructure investment continued to be impacted by the pandemic. Non-GAAP gross margin for the quarter expanded almost 100 basis points sequentially to 38.7%. Margins benefited from substantially better than expected product mix and material cost and positive other cost-of-sale items, partially offset by increased costs related to COVID. In addition, we improved factory utilization overall and are beginning to see the impact of some of our synergy actions. Although, we do not expect all of these favorable items to repeat next quarter, we continue to make steady progress on our goal to improve overall gross margins to greater than 40%. Non-GAAP operating expenses were $77.8 million, up $3 million from last quarter, primarily related to increased R&D investments and variable expenses associated with the higher revenues. Expense as a percent of sales improved almost 100 basis points, demonstrating the synergy and leverage in our model and at under 23% of sales is in the top quartile of our competitors, even as we continue to make critical investments to drive growth. Non-GAAP operating income improved to $53.8 million and 15.8% of revenue. Non-GAAP other expense was approximately $500,000, down from $3.5 million last quarter, primarily on the timing of an insurance claim and subsequent recovery and on lower net interest expense. We expect total other expense to be in the $1 million to $1.5 million range going forward. Our non-GAAP tax expense was $7.9 million or 14.7%, primarily as a result of integrating Artesyn into our structure and favorable mix of foreign earnings. Looking forward, we expect the GAAP and non-GAAP tax rates remain around 15% to 17%. Non-GAAP earnings for the quarter was $1.18 per share, up 30% from $0.91 last quarter on higher revenue and margins. EPS was up over 150% from $0.45 a year ago. The Artesyn acquisition continues to contribute positively to our consolidated results. The acquisition was solidly accretive in Q2 adding over $0.30 per share to non-GAAP earnings, including the interest expense of financing, and as at the end of Q2, realized synergies to date were over $20 million. As a result, we have largely achieved our Phase 1 synergy goals after the first-three quarters, well ahead of our original plan of 18 months to 24 months. As we integrate Artesyn, we have found new opportunities to further improve our costs, allowing us to reinvest part of the achieved synergies into R&D to drive faster long-term growth, while keeping our long-term operating margin goal of over 20%. Based on the great progress we have made, we remain confident in meeting or exceeding our long-term targets of $40 million of annualized synergies and $1.50 per share in EPS accretion. Turning now to the balance sheet, we ended the quarter with cash and marketable securities of $383 million, up $28 million from Q1. Operating cash flow from continuing operations was $38.6 million, our highest level since Q2 of 2018. Receivables increased on higher sales and DSO rose by one day to 62 days. Inventory increased by $25 million and turns were 3.2 times, reflecting investments we made to manage risk in the COVID environment. Payables were $180 million, representing 77 days of DPO. Total days of net working capital were 97, up six days from last quarter. Capital expenditures for the quarter were $7.3 million and depreciation was $6.6 million. During the quarter, we repaid $4.4 million of debt and ended with total bank debt of $331 million, resulting in gross debt leverage of 1.8 times. We did not repurchase any shares during the quarter. Now, let me turn to guidance. In the near term, we continue to see strong demand in our semiconductor market and anticipate continued modest improvement in industrial and medical. We expect demand in the data center computing, and telecom and networking markets to fluctuate at around the current levels. However, we continue to see changes in the environment related to COVID-19 as many governments re-implement certain levels of quarantine. Factoring in the limited visibility and ongoing operating and macroeconomic risk related to COVID, we are guiding Q3 revenue to $350 million, plus or minus $25 million. Based on anticipated mix, volume and ongoing COVID-related costs, we expect non-GAAP gross margins to be in the 37% to 38% range, up 150 basis points from last quarter's guidance as we gain more traction on our synergy and structural improvements. Operating expenses are expected to be about flat, including increased engineering investment related to a new advanced dielectric etch evaluation program with a strategic OEM. As a result, we expect non-GAAP earnings at $1.15 per share, plus or minus $0.25. To summarize, we delivered a great quarter operationally and financially with record revenues, improvement in gross margin and operating margins, and almost 30% sequential increase to our non-GAAP earnings. Our pure play power strategy is enabling us to capitalize on market and technology trends across many of our verticals, accelerate growth, and realize synergy and operating benefits ahead of our plan. We are well on our way to building the business and financial model of a top-tier industrial technology company and we are on track to meeting or exceeding our stated long-term aspirational goals. With that, we will take your questions. Operator?